Mission Creek Capital Partners’s Teladoc Health TDOC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q3
Sell
-42,552
Closed -$1.41M 214
2022
Q2
$1.41M Hold
42,552
0.47% 78
2022
Q1
$3.07M Hold
42,552
0.82% 30
2021
Q4
$3.91M Buy
42,552
+37,209
+696% +$4.45M 0.78% 26
2021
Q3
$680K Buy
5,343
+3,477
+186% +$506K 0.13% 152
2021
Q2
$310K Sell
1,866
-25,149
-93% -$4.07M 0.05% 198
2021
Q1
$4.91M Buy
+27,015
New +$6.27M 0.73% 16

Other funds holding TDOC

Mission Creek Capital Partners's TDOC Position: Q3 2022 in Review

Mission Creek Capital Partners sold out of Teladoc Health (TDOC) in Q3 2022, closing a stake of 42,552 shares — an estimated $1.41M sold.

Mission Creek Capital Partners first reported a position in TDOC in Q1 2021 and held it in 6 quarters. The position peaked at $4.91M in Q1 2021. 482 funds tracked by Wall St. Rank hold TDOC as of Q3 2022.

  • Mission Creek Capital Partners reported no remaining Teladoc Health position as of Q3 2022 after selling out during the quarter.
  • Mission Creek Capital Partners sold 42,552 Teladoc Health shares in Q3 2022, an estimated $1.41M.
  • Mission Creek Capital Partners first reported a position in Teladoc Health in Q1 2021 and held it in 6 quarters.
  • Mission Creek Capital Partners's Teladoc Health position peaked at $4.91M in Q1 2021.
  • 482 funds tracked by Wall St. Rank held Teladoc Health as of Q3 2022.

Based on Mission Creek Capital Partners's 13F filing for Q3 2022, filed 14 Nov 2022.